These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11535515)

  • 1. Phenotype changes resulting in high-affinity binding of von Willebrand factor to recombinant glycoprotein Ib-IX: analysis of the platelet-type von Willebrand disease mutations.
    Tait AS; Cranmer SL; Jackson SP; Dawes IW; Chong BH
    Blood; 2001 Sep; 98(6):1812-8. PubMed ID: 11535515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycoprotein (GP) Ib-IX-transfected cells roll on a von Willebrand factor matrix under flow. Importance of the GPib/actin-binding protein (ABP-280) interaction in maintaining adhesion under high shear.
    Cranmer SL; Ulsemer P; Cooke BM; Salem HH; de la Salle C; Lanza F; Jackson SP
    J Biol Chem; 1999 Mar; 274(10):6097-106. PubMed ID: 10037692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
    Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
    Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and functional characterization of a novel 27-bp deletion in the macroglycopeptide-coding region of the GPIBA gene resulting in platelet-type von Willebrand disease.
    Othman M; Notley C; Lavender FL; White H; Byrne CD; Lillicrap D; O'Shaughnessy DF
    Blood; 2005 Jun; 105(11):4330-6. PubMed ID: 15705799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets.
    Hillery CA; Mancuso DJ; Evan Sadler J; Ponder JW; Jozwiak MA; Christopherson PA; Cox Gill J; Paul Scott J; Montgomery RR
    Blood; 1998 Mar; 91(5):1572-81. PubMed ID: 9473222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel platelet-type von Willebrand disease mutation (GP1BA p.Met255Ile) associated with type 2B "Malmö/New York" von Willebrand disease.
    Lavenu-Bombled C; Guitton C; Dupuis A; Baas MJ; Desconclois C; Dreyfus M; Li R; Caron C; Gachet C; Fressinaud E; Lanza F
    Thromb Haemost; 2016 Nov; 116(6):1070-1078. PubMed ID: 27683759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of GPIbalpha-vWF-A1 tether bond under flow: effect of GPIbalpha mutations on the association and dissociation rates.
    Kumar RA; Dong JF; Thaggard JA; Cruz MA; López JA; McIntire LV
    Biophys J; 2003 Dec; 85(6):4099-109. PubMed ID: 14645097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visualizing the von Willebrand factor/glycoprotein Ib-IX axis with a platelet-type von Willebrand disease mutation.
    Guerrero JA; Kyei M; Russell S; Liu J; Gartner TK; Storrie B; Ware J
    Blood; 2009 Dec; 114(27):5541-6. PubMed ID: 19808696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The glycoprotein Ibalpha-von Willebrand factor interaction induces platelet apoptosis.
    Li S; Wang Z; Liao Y; Zhang W; Shi Q; Yan R; Ruan C; Dai K
    J Thromb Haemost; 2010 Feb; 8(2):341-50. PubMed ID: 19840363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N1421K mutation in the glycoprotein Ib binding domain impairs ristocetin- and botrocetin-mediated binding of von Willebrand factor to platelets.
    Lanke E; Kristoffersson AC; Isaksson C; Holmberg L; Lethagen S
    Eur J Haematol; 2008 Nov; 81(5):384-90. PubMed ID: 18637125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in the intrinsic properties of the GPIbalpha-VWF tether bond define the kinetics of the platelet-type von Willebrand disease mutation, Gly233Val.
    Doggett TA; Girdhar G; Lawshe A; Miller JL; Laurenzi IJ; Diamond SL; Diacovo TG
    Blood; 2003 Jul; 102(1):152-60. PubMed ID: 12637314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and functional characterization of an abnormal platelet membrane glycoprotein Ib alpha (Met239 --> Val) reported in patients with platelet-type von Willebrand disease.
    Moriki T; Murata M; Kitaguchi T; Anbo H; Handa M; Watanabe K; Takahashi H; Ikeda Y
    Blood; 1997 Jul; 90(2):698-705. PubMed ID: 9226170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the phenotypic abnormality of platelet-type von Willebrand disease in a recombinant glycoprotein Ib alpha fragment.
    Murata M; Russell SR; Ruggeri ZM; Ware J
    J Clin Invest; 1993 May; 91(5):2133-7. PubMed ID: 8486780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel gain-of-function mutations of platelet glycoprotein IBalpha by valine mutagenesis in the Cys209-Cys248 disulfide loop. Functional analysis under statis and dynamic conditions.
    Dong J; Schade AJ; Romo GM; Andrews RK; Gao S; McIntire LV; López JA
    J Biol Chem; 2000 Sep; 275(36):27663-70. PubMed ID: 10837490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel point mutation in platelet glycoprotein Ibalpha, Gly to Ser at residue 233, in a Japanese family with platelet-type von Willebrand disease.
    Matsubara Y; Murata M; Sugita K; Ikeda Y
    J Thromb Haemost; 2003 Oct; 1(10):2198-205. PubMed ID: 14521605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF.
    Yago T; Lou J; Wu T; Yang J; Miner JJ; Coburn L; López JA; Cruz MA; Dong JF; McIntire LV; McEver RP; Zhu C
    J Clin Invest; 2008 Sep; 118(9):3195-207. PubMed ID: 18725999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease.
    Stepanian A; Ribba AS; Lavergne JM; Fressinaud E; Juhan-Vague I; Mazurier C; Girma JP; Meyer D
    Br J Haematol; 2003 Feb; 120(4):643-51. PubMed ID: 12588351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel von Willebrand factor mutation (I1372S) associated with type 2B-like von Willebrand disease: an elusive phenotype and a difficult diagnosis.
    Casonato A; Sartorello F; Pontara E; Gallinaro L; Bertomoro A; Grazia Cattini M; Daidone V; Szukowska M; Pagnan A
    Thromb Haemost; 2007 Dec; 98(6):1182-7. PubMed ID: 18064311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mucin-like macroglycopeptide region of glycoprotein Ibalpha is required for cell adhesion to immobilized von Willebrand factor (VWF) under flow but not for static VWF binding.
    Li CQ; Dong JF; López JA
    Thromb Haemost; 2002 Oct; 88(4):673-7. PubMed ID: 12362242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The membrane-proximal intermolecular disulfide bonds in glycoprotein Ib influence receptor binding to von Willebrand factor.
    Mo X; Luo SZ; Munday AD; Sun W; Berndt MC; López JA; Dong JF; Li R
    J Thromb Haemost; 2008 Oct; 6(10):1789-95. PubMed ID: 18647229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.